Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SNBR Stock Summary
Top 10 Correlated ETFs
SNBR
In the News
Sleep Number: Some Light At The End Of The Tunnel
Sleep Number Corporation stock has lost over half its value in the past year, while the benchmark has risen by close to a third. We touch upon some of the negative sub-plots that have weighed on the stock. Whilst the industry may not grow this year as well, we are encouraged by the steps that the company is taking to address its cost-base and generate free cash flow.
New Strong Sell Stocks for March 15th
AGL, BFIN and SNBR have been added to the Zacks Rank #5 (Strong Sell) List on March 15, 2024.
Sleep Number Stock Wakes Up on Restructuring Plans
Sleep Number Co. NASDAQ: SNBR shares jumped 33% on its Q4 2023 earnings release. The consumer discretionary sector company is a leading manufacturer of smart adjustable beds and accessories.
Sleep Number (SNBR) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Sleep Number (SNBR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Here's Why Sleep Number Stock Skyrocketed Today
Sleep Number and other premium mattress brands are dealing with soft consumer demand, impacting sales and profitability. The company expects positive free cash flow in 2024, which has investors excited.
Sleep Number Corporation (SNBR) Q4 2023 Earnings Call Transcript
Sleep Number Corporation (SNBR) Q4 2023 Earnings Call Transcript
Sleep Number (SNBR) Reports Q4 Loss, Tops Revenue Estimates
Sleep Number (SNBR) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares to loss of $0.24 per share a year ago.
Sleep Number: Not A High Growth Company, But An Investment Opportunity
SNBR's revenue growth has been driven more by price growth than volume growth, indicating it is not a high-growth company. The company has repositioned itself as a wellness technology company, known for its innovative Sleep Number beds. Despite some mixed performance metrics, there is a 30% margin of safety when valuing SNBR based on the Earnings Power Value, making it an investment opportunity.
Don't Sleep On Sleep Number's Potential Earnings Recovery
Sleep Number manufactures and sells beds at a high price point, including smart capabilities through a mobile app. The company has faced challenges with decreasing demand and supply chain issues, along with a likely weakly perceived new product line relaunch. Sleep Number has a number of initiatives to improve earnings, including closings of 40-50 stores, and supply chain & marketing spend optimization.
3 more tax-loss selling buy opportunities
Tax-loss selling occurs as investors dump their underperforming stocks to take the capital loss and wait 30 days to buy them back to avoid the wash rule. This causes underperforming stocks to fall in December and bounce back in January and February as investors buy back into the same shares.
SNBR Financial details
SNBR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-30
Metric | History | 2019-12-28 | 2021-01-02 | 2022-01-01 | 2022-12-31 | 2023-12-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 57.63 | 67.11 | 90.9 | 84.75 | 84.15 | |
Net income per share | 2.78 | 5.03 | 6.4 | 1.47 | -0.68 | |
Operating cash flow per share | 6.42 | 10.11 | 12.48 | 1.45 | -0.49 | |
Free cash flow per share | 4.41 | 8.7 | 9.7 | -1.34 | -3.04 | |
Cash per share | 0.05 | 0.15 | 0.1 | 0.07 | 0.11 | |
Book value per share | -5.41 | -8.1 | -17.68 | -17.56 | -19.7 | |
Tangible book value per share | -7.89 | -10.73 | -20.61 | -20.29 | -22.67 | |
Share holders equity per share | -5.41 | -8.1 | -17.68 | -17.56 | -19.7 | |
Interest debt per share | 20.37 | 21.63 | 33.17 | 36.68 | 45.27 | |
Market cap | 1.46B | 2.26B | 1.84B | 648.12M | 332.62M | |
Enterprise value | 2.05B | 2.85B | 2.63B | 1.54B | 1.3B | |
P/E ratio | 17.86 | 16.27 | 11.98 | 17.7 | -21.76 | |
Price to sales ratio | 0.86 | 1.22 | 0.84 | 0.31 | 0.18 | |
POCF ratio | 7.73 | 8.1 | 6.14 | 17.93 | -30.12 | |
PFCF ratio | 11.25 | 9.41 | 7.9 | -19.45 | -4.88 | |
P/B Ratio | -9.17 | -10.11 | -4.33 | -1.48 | -0.75 | |
PTB ratio | -9.17 | -10.11 | -4.33 | -1.48 | -0.75 | |
EV to sales | 1.21 | 1.53 | 1.2 | 0.73 | 0.69 | |
Enterprise value over EBITDA | 11.78 | 11.56 | 10.36 | 11.4 | 11.73 | |
EV to operating cash flow | 10.83 | 10.19 | 8.77 | 42.68 | -117.95 | |
EV to free cash flow | 15.77 | 11.85 | 11.28 | -46.29 | -19.13 | |
Earnings yield | 0.06 | 0.06 | 0.08 | 0.06 | -0.05 | |
Free cash flow yield | 0.09 | 0.11 | 0.13 | -0.05 | -0.2 | |
Debt to equity | -3.69 | -2.63 | -1.86 | -2.04 | -2.2 | |
Debt to assets | 0.73 | 0.74 | 0.86 | 0.94 | 0.89 | |
Net debt to EBITDA | 3.37 | 2.37 | 3.11 | 6.61 | 8.73 | |
Current ratio | 0.27 | 0.28 | 0.23 | 0.21 | 0.22 | |
Interest coverage | 9.67 | 20.72 | 30.99 | 3.58 | 0.91 | |
Income quality | 2.31 | 2.01 | 1.95 | 0.99 | 0.72 | |
Dividend Yield | 0.02 | 0.01 | 0.08 | 0.15 | 0.21 | |
Payout ratio | 0.32 | 0.08 | 0.95 | 2.67 | -4.67 | |
Sales general and administrative to revenue | 0.08 | 0.09 | 0.07 | 0.07 | 0.08 | |
Research and developement to revenue | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.09 | 0.09 | 0.08 | 0.07 | 0.06 | |
Capex to operating cash flow | -0.31 | -0.14 | -0.22 | -1.92 | 5.17 | |
Capex to revenue | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -0.96 | -0.63 | -1.11 | -1.03 | -0.79 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 18.39 | 30.27 | 50.44 | 24.08 | 17.38 | |
ROIC | 0.12 | 0.21 | 0.21 | 0.06 | 0.03 | |
Return on tangible assets | 0.11 | 0.19 | 0.18 | 0.04 | -0.01 | |
Graham Net | -30.72 | -34.53 | -52.83 | -52.66 | -63.75 | |
Working capital | -434.41M | -474.14M | -699.16M | -732.06M | -729.94M | |
Tangible asset value | -232.66M | -296.85M | -495.42M | -506.24M | -508.56M | |
Net current asset value | -805.11M | -842.31M | -1.14B | -1.19B | -1.33B | |
Invested capital | -3.69 | -2.63 | -1.86 | -2.04 | -2.2 | |
Average receivables | 22.39M | 25.92M | 28.79M | 25.86M | 40.72M | |
Average payables | 139.69M | 113.25M | 127.23M | 169.38M | 156.05M | |
Average inventory | 85.97M | 84.21M | 93.5M | 109.84M | 114.73M | |
Days sales outstanding | 4.29 | 6.27 | 4.3 | 4.49 | 10.72 | |
Days payables outstanding | 76 | 47.88 | 68.5 | 70.52 | 63.35 | |
Days of inventory on hand | 49.16 | 42.39 | 44.52 | 45.64 | 53.81 | |
Receivables turnover | 85.01 | 58.25 | 84.96 | 81.3 | 34.05 | |
Payables turnover | 4.8 | 7.62 | 5.33 | 5.18 | 5.76 | |
Inventory turnover | 7.42 | 8.61 | 8.2 | 8 | 6.78 | |
ROE | -0.51 | -0.62 | -0.36 | -0.08 | 0.03 | |
Capex per share | -2.01 | -1.41 | -2.78 | -2.78 | -2.54 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-30 for Q4
Metric | History | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.45 | 23.62 | 20.43 | 21.03 | 19.1 | |
Net income per share | -0.25 | 0.51 | 0.03 | -0.1 | -1.12 | |
Operating cash flow per share | -1.98 | 0.83 | 0.01 | 0.58 | -1.89 | |
Free cash flow per share | -2.74 | 0.14 | -0.63 | -0.22 | -2.29 | |
Cash per share | 0.08 | 0.07 | 0.08 | 0.04 | 0.11 | |
Book value per share | -19.77 | -19.06 | -18.66 | -18.71 | -19.66 | |
Tangible book value per share | -22.84 | -22.09 | -21.65 | -21.68 | -22.62 | |
Share holders equity per share | -19.77 | -19.06 | -18.66 | -18.71 | -19.66 | |
Interest debt per share | 40.78 | 41.11 | 41.51 | 41.76 | 43.83 | |
Market cap | 575.72M | 678.02M | 612.71M | 552.76M | 333.42M | |
Enterprise value | 1.47B | 1.58B | 1.53B | 1.48B | 1.3B | |
P/E ratio | -26.51 | 14.78 | 203.15 | -59.62 | -3.31 | |
Price to sales ratio | 1.16 | 1.29 | 1.34 | 1.17 | 0.78 | |
POCF ratio | -13.09 | 36.49 | 4.41K | 42.21 | -7.86 | |
PFCF ratio | -9.5 | 224.14 | -43.14 | -109.96 | -6.48 | |
P/B Ratio | -1.31 | -1.6 | -1.46 | -1.31 | -0.75 | |
PTB ratio | -1.31 | -1.6 | -1.46 | -1.31 | -0.75 | |
EV to sales | 2.95 | 3.01 | 3.34 | 3.13 | 3.03 | |
Enterprise value over EBITDA | 77.48 | 35.88 | 51.52 | 62.08 | 92.4 | |
EV to operating cash flow | -33.42 | 85.25 | 11.03K | 112.98 | -30.72 | |
EV to free cash flow | -24.24 | 523.67 | -107.94 | -294.33 | -25.33 | |
Earnings yield | -0.01 | 0.02 | 0 | 0 | -0.08 | |
Free cash flow yield | -0.11 | 0 | -0.02 | -0.01 | -0.15 | |
Debt to equity | -2.04 | -2.14 | -2.2 | -2.21 | -2.2 | |
Debt to assets | 0.94 | 0.94 | 0.96 | 0.97 | 0.89 | |
Net debt to EBITDA | 47.14 | 20.52 | 30.93 | 38.89 | 68.76 | |
Current ratio | 0.21 | 0.23 | 0.23 | 0.22 | 0.22 | |
Interest coverage | 0.12 | 2.85 | 1.13 | 0.49 | -0.31 | |
Income quality | 8.1 | 1.62 | 0.18 | -5.65 | 1.68 | |
Dividend Yield | 0.11 | 0 | 0.02 | 0 | 0 | |
Payout ratio | -11.58 | 0.03 | 20 | 0 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.07 | 0.09 | 0.07 | 0.08 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | |
Capex to operating cash flow | 0.38 | -0.84 | -103.19 | -1.38 | 0.21 | |
Capex to revenue | -0.03 | -0.03 | -0.03 | -0.04 | -0.02 | |
Capex to depreciation | -0.92 | -0.85 | -0.77 | -0.98 | -0.5 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Graham number | 10.44 | 14.85 | 3.75 | 6.59 | 22.26 | |
ROIC | 0 | 0.02 | 0.01 | 0 | 0 | |
Return on tangible assets | -0.01 | 0.01 | 0 | 0 | -0.02 | |
Graham Net | -59.29 | -58.78 | -58.05 | -58.22 | -63.59 | |
Working capital | -732.06M | -717.28M | -713.25M | -721.26M | -729.94M | |
Tangible asset value | -506.24M | -492.61M | -486.23M | -487.38M | -508.56M | |
Net current asset value | -1.19B | -1.18B | -1.18B | -1.18B | -1.33B | |
Invested capital | -2.04 | -2.14 | -2.2 | -2.21 | -2.2 | |
Average receivables | 26.38M | 24.65M | 23.7M | 21.37M | 37.03M | |
Average payables | 187.68M | 168.26M | 156.25M | 160.54M | 152.39M | |
Average inventory | 113.79M | 115.41M | 119.11M | 118.84M | 115.83M | |
Days sales outstanding | 4.7 | 3.98 | 4.73 | 3.55 | 11.61 | |
Days payables outstanding | 70.31 | 66.71 | 70.41 | 75.42 | 66.84 | |
Days of inventory on hand | 45.5 | 48.6 | 56.18 | 51.9 | 56.77 | |
Receivables turnover | 19.13 | 22.61 | 19.04 | 25.37 | 7.75 | |
Payables turnover | 1.28 | 1.35 | 1.28 | 1.19 | 1.35 | |
Inventory turnover | 1.98 | 1.85 | 1.6 | 1.73 | 1.59 | |
ROE | 0.01 | -0.03 | 0 | 0.01 | 0.06 | |
Capex per share | -0.75 | -0.7 | -0.64 | -0.81 | -0.4 |
SNBR Frequently Asked Questions
What is Sleep Number Corporation stock symbol ?
Sleep Number Corporation is a US stock , located in Minneapolis of Mn and trading under the symbol SNBR
Is Sleep Number Corporation buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $44.5. The lowest prediction is $40 and the highest is $49
What is SNBR stock prediction ?
What is Sleep Number Corporation stock quote today ?
Sleep Number Corporation stock price is $16.03 today.
Is Sleep Number Corporation stock public?
Yes, Sleep Number Corporation is a publicly traded company.